| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.15 | 0.08 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |